Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Armgo Pharma
AddedFeb 15, 2024
UpdatedJun 18, 2026
Armgo Pharma

Armgo Pharma

Series B

ARMGO Pharma, Inc., a US-based company, develops and distributes therapeutic pharmaceuticals for cardiac, muscular, and neurological disorders.

HQ
Tarrytown, NY, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

ARMGO Pharma, Inc., founded in Tarrytown, United States, is a privately owned, venture-backed biotech company focused on developing small-molecule therapeutics for debilitating cardiac, muscular, and neurological disorders. The company's core mission is to treat diseases related to leaky Ryanodine Receptor (RyR) calcium channels. ARMGO Pharma holds an exclusive worldwide license from Columbia University for its RyR technology and know-how. Their primary focus is on orphan diseases, including the life-threatening cardiac condition Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).

Notable affiliated individuals include scientists and researchers from Columbia University, who contribute to the development of their proprietary technology. ARMGO Pharma has attracted significant venture capital investment, underscoring confidence in their innovative approach. Key achievements include the development of promising drug candidates that have shown efficacy in preclinical models. The company's impact lies in its potential to offer new treatment options for patients suffering from rare and severe RyR-related diseases, addressing significant unmet medical needs.

Armgo Pharma - Similar Companies

Adrx logo

Adrx

adrxpharma.com

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Armata Pharmaceuticals logo

Armata Pharmaceuticals

armatapharma.com

Argentis Pharmaceuticals logo

Argentis Pharmaceuticals

argentisrx.com

Armetheon logo

Armetheon

Amulet Pharmaceuticals logo

Amulet Pharmaceuticals

ArgiNOx Phamaceuticals logo

ArgiNOx Phamaceuticals

Cargene logo

Cargene

cargene.com

Underdog Pharmaceuticals logo

Underdog Pharmaceuticals

cyclaritytx.com

Aggamin logo

Aggamin

Arrogene logo

Arrogene

Aro Biotherapeutics logo

Aro Biotherapeutics

arobiotx.com

Rho Pharmaceuticals logo

Rho Pharmaceuticals

Armr Systems logo

Armr Systems

armrsystems.com

Myotherix logo

Myotherix

Armgo Pharma - Quick Facts

Who are Armgo Pharma's competitors?

Companies similar to Armgo Pharma include Adrx, Aria Pharmaceuticals, Armata Pharmaceuticals and Argentis Pharmaceuticals.

When was Armgo Pharma founded?

Armgo Pharma was founded in 2004.

Where is Armgo Pharma's headquarters located?

Armgo Pharma's headquarters is located in Tarrytown, NY, US.

When was Armgo Pharma's last funding round?

Armgo Pharma's most recent funding round was for $35M (USD) in December 2021.

How much has Armgo Pharma raised to-date?

As of Dec 20, 2021, Armgo Pharma has raised a total of $36M (USD).

How many employees does Armgo Pharma have?

Armgo Pharma has 11 employees as of Feb 5, 2024.

Armgo Pharma - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
  • 4772Retail sale of pharmaceutical and medical goods, cosmetic and toilet articles in specialized stores
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 456100Health and Personal Care Retailers
  • 325410Pharmaceutical and Medicine Manufacturing
  • 456110Pharmacies and Drug Retailers
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 5900Miscellaneous Retail
  • 8000Health Services
  • 2830Drugs
  • 5910Drug Stores And Proprietary Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 5912Drug Stores and Proprietary Stores
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified